| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/23/2007 | WO2007094781A1 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
| 08/23/2007 | WO2007093608A1 Drug combinations for the treatment of respiratory tract diseases |
| 08/23/2007 | WO2007093595A1 Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 08/23/2007 | WO2007093328A1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 08/23/2007 | WO2007071839A3 Potentiation of apoptosis by monoclonal antibodies |
| 08/23/2007 | WO2007022165A3 Factor xa inhibitor inclusion complex with cyclodextrin |
| 08/23/2007 | WO2007014798A3 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 08/23/2007 | US20070197637 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197496 for modulating cellular levels of oxidants such as superoxide radicals, hydrogen peroxide, peroxynitrite, lipid peroxides, hydroxyl radicals and thiyl radicals, treating diabetes mellitus Type I or Type II |
| 08/23/2007 | US20070197475 includes rapidly excretable perfluororganic compounds e.g. perfluordecalin, perfluoractilbromide, a perfluoroganic additive embodied in the form of a mixture of perfluorinated tertiary amines contains perfluorotripropylamine and coproducts; and phospholipids in the form of a water-salt dispersion |
| 08/23/2007 | US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/23/2007 | US20070197449 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 08/23/2007 | US20070196526 Agent for substitution of blood plasma and a method of its production |
| 08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
| 08/23/2007 | US20070196347 Methods for preventing neurological events |
| 08/23/2007 | DE102006007146A1 Aminoacyl-Prodrugs Aminoacyl prodrugs |
| 08/23/2007 | DE102006006905A1 Mittel zur Blutstillung Means for hemostasis |
| 08/23/2007 | CA2642389A1 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia |
| 08/23/2007 | CA2642239A1 Drug combinations for the treatment of respiratory tract diseases |
| 08/23/2007 | CA2641912A1 Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 08/22/2007 | EP1820516A2 Novel albumin-free factor VIII formulations |
| 08/22/2007 | EP1820509A1 Therapeutic preparation of very high purity FVlla and method for obtaining same |
| 08/22/2007 | EP1820508A1 Coagulation factor X polypeptides with modified activation properties |
| 08/22/2007 | EP1820506A1 Dipyridamole extended-release formulations and process for preparing same |
| 08/22/2007 | EP1820501A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 08/22/2007 | EP1819720A1 A cost-effective process for preparation of manufacture of iron sucrose |
| 08/22/2007 | EP1819703A1 Crytalline forms of a pyrazolo `3, 4-c ü pyridine factor xa inhibitor |
| 08/22/2007 | EP1819701A1 Cyclic iminocarbamates and use thereof |
| 08/22/2007 | EP1819693A1 Antithrombotic diamides |
| 08/22/2007 | EP1819692A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 08/22/2007 | EP1819334A1 Methods of treating erythropoietin-resistance |
| 08/22/2007 | EP1303292A4 Chemokine conjugates |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
| 08/22/2007 | CN1332690C Technique for preparing Yueju capsule and quality control method |
| 08/22/2007 | CN1332660C Hemostatic injection of carbazochrome sodium sulfonate and method for preparing the same |
| 08/22/2007 | CN101020637A Prepn process and application of resemary acid |
| 08/22/2007 | CN101019983A Chinese medicine for treating allergic purpura |
| 08/22/2007 | CN101019964A Health wine with leech and its production process |
| 08/22/2007 | CN101019915A Hemostatic notoginseng capsuel and its prepn process and quality control method |
| 08/22/2007 | CN101019890A Donkey-hide gelatin degrading product |
| 08/22/2007 | CN101019873A Compound coenzyme Q10 medicine prepn and its prepn process and application |
| 08/22/2007 | CN101019645A Health food for remitting fatigue and raising hypoxia tolerance and its prepn |
| 08/21/2007 | US7259181 β crystalline form of perindopril tert-butylamine salt |
| 08/21/2007 | US7259148 Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid |
| 08/21/2007 | US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema. |
| 08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 08/21/2007 | CA2165995C Medicaments for the treatment of restenosis and arterial sclerosis |
| 08/21/2007 | CA2139468C Methods for preventing degradation of protein c |
| 08/16/2007 | WO2007092469A2 Combination of organic compounds |
| 08/16/2007 | WO2007092026A1 Dipyridamole extended-release formulations and process for preparing same |
| 08/16/2007 | WO2007091719A1 Concomitant anti-gpvi antibody therapy and novel medicinal use thereof |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007091350A1 Solid-phase membrane containing surface-modified albumin or surface-modified serum albumin-metal porphyrin complex and use thereof |
| 08/16/2007 | WO2007090368A1 Method and device for producing haemostatic wound dressings without chemical additives |
| 08/16/2007 | WO2007065594A3 Unsaturated fatty acids as thrombin inhibitors |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191478 Methods of treating cardio pulmonary diseases with NO group compounds |
| 08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2007 | US20070190634 Compositions useful as inhibitors of protein kinases |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190152 Method for providing an active agent topically to the skin |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | DE202006015207U1 Verwendung vn Plasminogenaktivatoren zur Behandlung einer Venenthromboembolie Use vn plasminogen activators for the treatment of venous thromboembolism |
| 08/16/2007 | CA2640472A1 Dipyridamole extended-release formulations and process for preparing same |
| 08/16/2007 | CA2637792A1 Combination of organic compounds |
| 08/15/2007 | EP1818330A1 Substituted proline amides, preparation and use as medicaments thereof |
| 08/15/2007 | EP1818047A2 Oral administration form for difficulty soluble basic active ingredients |
| 08/15/2007 | EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 08/15/2007 | EP1542705B1 Anticoagulant composition |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1355588B1 Device for delivery of therepeutic agents |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1232251B1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 08/15/2007 | EP0752874B1 Enhanced virus-mediated dna transfer |
| 08/15/2007 | CN1332019C Grifola umbellate zymophyte powder and grifola umbellate polysaccharide producing method and products therefrom |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101016557A Muskrat fragrant active component prepared by external secretion, preparing process and use |
| 08/15/2007 | CN101015686A Thrombolytic medicine synergist and its preparing process |
| 08/15/2007 | CN101015684A Recombinant erythropoietin liquor preparation |
| 08/15/2007 | CN101015677A Traditional Chinese powder medicine for treating broiler ascites and preparation process thereof |
| 08/15/2007 | CN101015647A Traditional Chinese medicine composition for treating hepatocirrhosis and liver ascites |
| 08/15/2007 | CN101015640A Dragon's blood dropping pill and its preparing process |
| 08/15/2007 | CN101015633A Medicine for treating postpartum disease caused by heat-induced blood extravasation and preparing method and use thereof |
| 08/15/2007 | CN101015630A Traditional Chinese medicine soft capsule and its preparing process and quality controlling means |
| 08/15/2007 | CN101015624A Traditional Chinese medicine for treating hemopathy |
| 08/15/2007 | CN101015614A Quality controlling means of Jiuwei hematopoietic oral liquid |
| 08/15/2007 | CN101015607A Traditional Chinese medicine for treating immune thrombocytopenic purpura and preparing method thereof |
| 08/15/2007 | CN101015602A Externally used traditional Chinese medicine for treating hepatitis B and hepatic ascites |
| 08/15/2007 | CN101015570A Children's health food of probiotics and its production process |
| 08/15/2007 | CN101015537A Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule |
| 08/15/2007 | CN101015536A Sustained release preparation containing cilostazol and its preparation method |
| 08/15/2007 | CN101015355A Preparing method of squid melanin iron and application thereof |